2 studies found for:    8380315 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Gemcitabine and CT-011 for Resected Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of the Pancreas;   Neoplasms Pancreatic;   Pancreatic Cancer;   Pancreas Cancer
Interventions: Biological: CT-011;   Drug: Gemcitabine
2 Withdrawn A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .
Condition: Pancreatic Cancer
Intervention: Other: Neoadjuvant capecitabine, panitumumab and radiation

Indicates status has not been verified in more than two years